Why the study?
Does intravenous nitroglycerin reduce infarct size in patients with acute myocardial infarction?
Does intravenous nitroglycerin reduce infarct size in patients with acute myocardial infarction?
Intravenous nitroglycerin reduces infarct size and improves clinical parameters in acute myocardial infarction, challenging historical contraindications.
No takes yet. Share an insight, caveat, or question.
Supports intravenous nitroglycerin to limit infarct size in acute MI; challenges historical contraindications and extends prior evidence.
W.‐D. Bussmann (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: